Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Acetamide, N-[2-[(5-chloro-2 methoxyphenyl)amino]-4'-methyl[4,5'-bithiazol]-2'-yl]-inhibits pro-matrix metalloproteinase activation and can be used to prevent, treat or ameliorate MMP9 and/or MMP13-mediated syndromes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 58.00 | |
5 mg | In stock | $ 133.00 | |
10 mg | In stock | $ 198.00 | |
25 mg | In stock | $ 343.00 | |
50 mg | In stock | $ 513.00 | |
100 mg | In stock | $ 746.00 | |
500 mg | In stock | $ 1,560.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 133.00 |
Description | Acetamide, N-[2-[(5-chloro-2 methoxyphenyl)amino]-4'-methyl[4,5'-bithiazol]-2'-yl]-inhibits pro-matrix metalloproteinase activation and can be used to prevent, treat or ameliorate MMP9 and/or MMP13-mediated syndromes. |
Targets&IC50 | TAOK2:1.1 µM |
Molecular Weight | 394.9 |
Formula | C16H15ClN4O2S2 |
CAS No. | 333746-76-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (126.61 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MMP-9-IN-7 333746-76-2 inhibitor inhibit